drugset / Trial / NCT02871349
Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response
Phase 0
Completed
69 enrolled
University of Missouri-Columbia
United States Department of Defense · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to find out how the brain of people with autism is affected by Propranolol. Propranolol is not FDA approved for the treatment of autism. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure This research is being done because there are currently no drug treatment options for language impairments and social difficulties often experienced by people with autism.
Timeline
- Start
- 2016-08
- Primary completion
- 2020-08
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propranolol | Small molecule | — | Oral |